MedTrace Logo

Long-term Assessment of Chlormethine Gel in Mycosis Fungoides

NCT07046663 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2025-07-04

No results posted yet for this study

Summary

The study aims to provide comprehensive insights into the long-term therapeutic outcomes, potential adverse effects, and overall patient experience with chlormethine gel, thereby informing clinical practice and guiding future treatment strategies for mycosis fungoides.

Conditions

  • Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Sponsors & Collaborators

  • Recordati Rare Diseases

    collaborator INDUSTRY

  • Fondazione Italiana Linfomi - ETS

    lead OTHER

Principal Investigators

  • Silvia Alberti Violetti · UOC Dermatologia - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07046663 on ClinicalTrials.gov